# Danaher Closes $9.9 Billion Acquisition of Masimo, Delists from Nasdaq

> ma · REPORTED · 2026-06-10

Danaher completed its $9.9 billion all-cash acquisition of patient monitoring company Masimo on June 10, 2026, with Masimo now operating as a wholly owned subsidiary within Danaher's diagnostics segment under the Masimo brand. Masimo common stock was delisted from the Nasdaq following the close.

- Company: Danaher / Masimo
- Sector: medical devices
- Primary source: https://www.ocbj.com/healthcare/danaher-closes-on-acquisition-of-masimo/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.